U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06909006) titled 'Semaglutide Treatment in Type 1 Diabetes' on March 17.
Brief Summary: The goal of this clinical trial is to investigate the efficacy of semaglutide on body weight, insulin dose requirements and improvements in glucose control and safety aspects in regards to risk of hypoglycemia and diabetic ketoacidosis for patients with established Type 1 Diabetes.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Obesity in Diabetes
Obesity/therapy
Type 1 Diabetes Mellitus (T1DM)
Insulin Sensitivity/Resistance
Semaglutide
Lipidomics
Metabolomics
Weight Loss
Glycemic Control for Diabetes Mellitus
Intervention:
DRUG: Semaglut...